Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-05-13

Clinical Trial Update: FMRF Combined With 30% SSA in the Treatment of Rosacea [NA]

View source ↗

Summary

This document provides an update on a completed clinical trial evaluating the combination of FMRF with 30% SSA for rosacea.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 30% SSA
  • FMRF

Snippet

Sponsor: Second Affiliated Hospital of Xi'an Jiaotong University | Conditions: Rosacea | NA | Status: COMPLETED